Breast Cancer Therapy
New breast cancer therapy research reported from Royal Marsden Hospital
Published in Cancer Weekly, October 9th, 2007
Research findings, 'Factors determining outcome after third line chemotherapy for metastatic breast cancer,' are discussed in a new report. According to recent research from London, the United Kingdom, "Patients with metastatic breast cancer (MBC) are increasingly offered third line chemotherapy. We have reviewed the response rate (RR), time to progression (TTP) and survival of 149 patients in this setting and have investigated factors that influence their outcome."
"The RR, TTP and survival were 30%, 4 and 8 months, respectively, and should serve as a benchmark for future studies. Response to previous chemotherapy was the only independent variable predicting RR, TTP...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-10-09)
More Articles from Cancer Weekly
- Cancer Gene Therapy
A search for biomarkers for early detection of colorectal cancer - Cancer Gene Therapy
Dr. Andrew I. Schafer Appointed Head of Department of Medicine at NYP/Weill Cornell - Cancer Gene Therapy
Jumping Genes' Could Make for Safer Gene Delivery System - Cancer Vaccines
New Screening Guidelines for Women at High Risk for Breast Cancer - Bioengineering
Cougar Biotechnology Appoints Samuel Saks to Board of Directors - Biologics
Bristol-Myers Squibb to Acquire Adnexus Therapeutics - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
